182 related articles for article (PubMed ID: 21247225)
1. A value set for the EQ-5D based on experienced health states: development and testing for the German population.
Leidl R; Reitmeir P
Pharmacoeconomics; 2011 Jun; 29(6):521-34. PubMed ID: 21247225
[TBL] [Abstract][Full Text] [Related]
2. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
3. An Experience-Based Value Set for the EQ-5D-5L in Germany.
Leidl R; Reitmeir P
Value Health; 2017 Sep; 20(8):1150-1156. PubMed ID: 28964448
[TBL] [Abstract][Full Text] [Related]
4. Assessing quality of life in a clinical study on heart rehabilitation patients: how well do value sets based on given or experienced health states reflect patients' valuations?
Leidl R; Schweikert B; Hahmann H; Steinacker JM; Reitmeir P
Health Qual Life Outcomes; 2016 Mar; 14():48. PubMed ID: 27005466
[TBL] [Abstract][Full Text] [Related]
5. US valuation of the EQ-5D health states: development and testing of the D1 valuation model.
Shaw JW; Johnson JA; Coons SJ
Med Care; 2005 Mar; 43(3):203-20. PubMed ID: 15725977
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
7. The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease.
Leidl R; Reitmeir P; König HH; Stark R
Value Health; 2012 Jan; 15(1):151-7. PubMed ID: 22264983
[TBL] [Abstract][Full Text] [Related]
8. Valuations of EQ-5D health states: are the United States and United Kingdom different?
Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
[TBL] [Abstract][Full Text] [Related]
9. 3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set.
Thomas S; Johnson JA; Xie F
Qual Life Res; 2020 Nov; 29(11):3109-3118. PubMed ID: 32705459
[TBL] [Abstract][Full Text] [Related]
10. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
[TBL] [Abstract][Full Text] [Related]
11. The valuation of the EQ-5D in Portugal.
Ferreira LN; Ferreira PL; Pereira LN; Oppe M
Qual Life Res; 2014 Mar; 23(2):413-23. PubMed ID: 23748906
[TBL] [Abstract][Full Text] [Related]
12. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
13. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.
Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA
Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899
[TBL] [Abstract][Full Text] [Related]
14. Chinese time trade-off values for EQ-5D health states.
Liu GG; Wu H; Li M; Gao C; Luo N
Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
[TBL] [Abstract][Full Text] [Related]
15. Using EQ-5D Data to Measure Hospital Performance: Are General Population Values Distorting Patients' Choices?
Gutacker N; Patton T; Shah K; Parkin D
Med Decis Making; 2020 May; 40(4):511-521. PubMed ID: 32486958
[No Abstract] [Full Text] [Related]
16. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
Kharroubi SA; O'Hagan A; Brazier JE
Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
[TBL] [Abstract][Full Text] [Related]
17. Social valuation of EQ-5D health states: the Chilean case.
Zarate V; Kind P; Valenzuela P; Vignau A; Olivares-Tirado P; Munoz A
Value Health; 2011 Dec; 14(8):1135-41. PubMed ID: 22152184
[TBL] [Abstract][Full Text] [Related]
18. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
Zarate V; Kind P; Chuang LH
Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
[TBL] [Abstract][Full Text] [Related]
19. Time Trade-Off Value Set for EQ-5D-3L Based on a Nationally Representative Chinese Population Survey.
Zhuo L; Xu L; Ye J; Sun S; Zhang Y; Burstrom K; Chen J
Value Health; 2018 Nov; 21(11):1330-1337. PubMed ID: 30442281
[TBL] [Abstract][Full Text] [Related]
20. Quality-of-life valuations of advanced breast cancer by New Zealand women.
Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
